What Are the Challenges in Targeting Cancer Genomes?
Targeting cancer genomes presents several challenges, including the heterogeneity of tumors, the dynamic nature of genetic changes, and the development of resistance to targeted therapies. Additionally, distinguishing between driver mutations that promote cancer and passenger mutations that do not contribute to cancer progression can be difficult. These challenges necessitate the continuous evolution of therapeutic approaches.
